Christine Barr

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli et al. · ACR Open Rheumatology · 2021 · 138 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cluster‐Randomized Trial of a Behavioral Intervention to Incorporate a Treat‐to‐Target Approach to Care of <scp>US</scp> Patients With Rheumatoid Arthritis

Leslie R. Harrold, George Reed, Ani John et al. · Arthritis Care & Research · 2017 · 36 citations · Full text

Medicine, Health Sciences, Behavioral Medicine +12

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Kyle Peake, John Manning, Coral-Ann Lewis et al. · Journal of Visualized Experiments · 2015 · 33 citations · Full text

Medicine, Hematology, Pharmacology +12

Myelosuppressive Conditioning Using Busulfan Enables Bone Marrow Cell Accumulation in the Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis

Coral-Ann Lewis, John Manning, Christine Barr et al. · PLoS ONE · 2013 · 22 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Sharing knowledge to advance healthcare policies in Europe for people living with dementia and their carers: the ALCOVE project

Christine Barr, N. Riolacci‐Dhoyen, Maggie Galbraith et al. · Archives of Public Health · 2012 · 14 citations · Full text

Medicine, Health Policy, Dementia +15